Fellowship · Columbus, OH
Sponsored by Ohio State University Hospital
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Dwight Owen
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.
The New England journal of medicine · 2021 · 1,378 citations · Sagar Sardesai
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
The New England journal of medicine · 2023 · 739 citations · Kari Kendra, Richard Wu
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
The New England journal of medicine · 2023 · 550 citations · Karilyn Larkin
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
The Lancet. Oncology · 2021 · 1,149 citations · David Carbone
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
The New England journal of medicine · 2023 · 713 citations ·
Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 213 citations · James Blachly
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Juraj Kavecansky